{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:48:39Z","timestamp":1778284119240,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":2446,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R21 HD070152-01A1"],"award-info":[{"award-number":["R21 HD070152-01A1"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003122","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003122","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.fertnstert.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T14:19:57Z","timestamp":1443277197000},"page":"214-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1129-6575","authenticated-orcid":false,"given":"Minnie","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Britten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeris","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2015.09.006_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/AOG.0b013e31820780e3","article-title":"Uterine leiomyomas: individualizing the approach to a heterogeneous condition","volume":"117","author":"Laughlin","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0033-1348896","article-title":"Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma","volume":"31","author":"Catherino","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1089\/jwh.2013.4597","article-title":"Uterine fibroid: the burden borne by African American women","volume":"22","author":"Richard-Davis","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib8","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1095\/biolreprod63.5.1322","article-title":"Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat","volume":"63","author":"Burroughs","year":"2000","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib9","first-page":"E1112","article-title":"Estrogen receptors (ERalpha\/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma","volume":"276","author":"Benassayag","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/molehr\/7.11.1085","article-title":"Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium","volume":"7","author":"Kovacs","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3109\/09513590.2011.569610","article-title":"Enhanced transcription of estrogen receptor \u03b1 and mitochondrial cytochrome b genes in uterine leiomyomas","volume":"27","author":"Shaik","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.fertnstert.2006.01.052","article-title":"Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans","volume":"86","author":"Al-Hendy","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib15","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1251483","article-title":"Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth","volume":"28","author":"Yoshida","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","article-title":"Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer","volume":"23","author":"Morikawa","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.fertnstert.2006.11.098","article-title":"Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor","volume":"88","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.fertnstert.2012.07.1123","article-title":"Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production","volume":"98","author":"Britten","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib20","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.fertnstert.2011.03.084","article-title":"Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells","volume":"95","author":"McCarthy-Keith","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/OGX.0000000000000036","article-title":"The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis","volume":"69","author":"Zhang","year":"2014","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsgi.2004.10.008","article-title":"Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas","volume":"12","author":"Di Lieto","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/107155760301000105","article-title":"Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma","volume":"10","author":"Chegini","year":"2003","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1472-6483(10)61957-8","article-title":"Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide)","volume":"3","author":"Felberbaum","year":"2001","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejogrb.2006.07.018","article-title":"Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study","volume":"134","author":"Engel","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2014.07.1238","article-title":"Fibroid growth and medical options for treatment","volume":"102","author":"Chabbert-Buffet","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib27","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.fertnstert.2006.08.111","article-title":"Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays","volume":"87","author":"Malik","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.fertnstert.2012.02.037","article-title":"Development and validation of a three-dimensional in\u00a0vitro model for uterine leiomyoma and patient-matched myometrium","volume":"97","author":"Malik","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1177\/1933719114545240","article-title":"Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures","volume":"21","author":"Malik","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","article-title":"Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells","volume":"69","author":"Malik","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Steward","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"28","author":"Malik","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.anireprosci.2005.05.009","article-title":"GnRH in non-hypothalamic reproductive tissues","volume":"88","author":"Ramakrishnappa","year":"2005","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1530\/REP-08-0397","article-title":"GnRH signaling in intrauterine tissues","volume":"137","author":"Wu","year":"2009","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib35","doi-asserted-by":"crossref","first-page":"521313","DOI":"10.1155\/2014\/521313","article-title":"Receptors of hypothalamic-pituitary-ovarian-axis hormone in uterine myomas","volume":"2014","author":"Plewka","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2004-828616","article-title":"Treatment strategies for uterine leiomyoma: the role of hormonal modulation","volume":"22","author":"Cook","year":"2004","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib37","doi-asserted-by":"crossref","first-page":"204236","DOI":"10.1155\/2012\/204236","article-title":"Estrogen regulates MAPK-Related Genes through genomic and nongenomic interactions between IGF-I receptor tyrosine kinase and estrogen receptor-alpha signaling pathways in human uterine leiomyoma cells","volume":"2012","author":"Yu","year":"2012","journal-title":"J Signal Transduct"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/humupd\/dmu056","article-title":"Role of nuclear progesterone receptor isoforms in uterine pathophysiology","volume":"21","author":"Patel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"267","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib40","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterus tissues after three months treatment in patients with symptomatic uterine leiomyomata","volume":"22","author":"Williams","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib41","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib42","first-page":"CD005287","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","volume":"10","author":"Deng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib45","first-page":"CD007687","article-title":"Mifepristone for uterine fibroids","volume":"8","author":"Tristan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7150\/ijms.7627","article-title":"Comparison of the inhibitory effect of gonadotropin releasing hormone (GnRH) agonist, selective estrogen receptor modulator (SERM), antiprogesterone on myoma cell proliferation in\u00a0vitro","volume":"11","author":"Chung","year":"2014","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425255.2012.695775","article-title":"Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment","volume":"8","author":"Melis","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib49","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.fertnstert.2014.01.054","article-title":"Nonobese diabetic\/severe combined immunodeficient murine xenograft model for human uterine leiomyoma","volume":"101","author":"Wang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000055275","article-title":"Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma","volume":"57","author":"Matsuo","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2119\/molmed.2014.00053","article-title":"Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy","volume":"21","author":"Borahay","year":"2015","journal-title":"Mol Med"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib52","first-page":"331","article-title":"The effect of medroxy-progesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol\/progestin treatment","volume":"22","author":"Lippert","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib53","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib54","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib55","first-page":"S181","article-title":"Mechanism of collagen biosynthesis up-regulation in cultured leiomyoma cells","volume":"45","author":"Zbucka","year":"2007","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib56","first-page":"10","article-title":"Sex steroidal modulation of collagen metabolism in uterine leiomyomas","volume":"36","author":"Ohara","year":"2009","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2005.12.020","article-title":"Extracellular matrix integrity: a possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens?","volume":"247","author":"Cox","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"8 Suppl","key":"10.1016\/j.fertnstert.2015.09.006_bib58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719107311464","article-title":"Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells","volume":"14","author":"Ohara","year":"2007","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/107155769800500109","article-title":"Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid","volume":"5","author":"Stewart","year":"1998","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib60","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1210\/jc.2004-0161","volume":"89","author":"Ding","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-cellbio-100109-104020","article-title":"Assembly of fibronectin extracellular matrix","volume":"26","author":"Singh","year":"2010","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2009.05296.x","article-title":"Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts","volume":"1193","author":"Soldano","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","article-title":"Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation","volume":"163","author":"Luo","year":"2014","journal-title":"Transl Res"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib64","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature07623","article-title":"Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis","volume":"457","author":"Kim","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10555-009-9182-y","article-title":"The biological role and regulation of versican levels in cancer","volume":"28","author":"Ricciardelli","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7827-9-22","article-title":"Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone","volume":"9","author":"Salgado","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10735-012-9476-1","article-title":"Estradiol induces transcriptional and posttranscriptional modifications in versican expression in the mouse uterus","volume":"44","author":"Salgado","year":"2013","journal-title":"J Mol Histol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib70","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.fertnstert.2014.03.042","article-title":"Liarozole inhibits transforming growth factor-beta3 (TGF-\u03b23) mediated extracellular matrix (ECM) formation in human 3-dimensional leiomyoma cultures","volume":"102","author":"Levy","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2015.01.023","article-title":"GnRH agonist reduces estrogen receptor dimerization in GT1-7 cells: evidence for cross-talk between membrane-initiated estrogen and GnRH signaling","volume":"404","author":"Chason","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.09.006_bib72","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.ddstr.2012.06.001","article-title":"Treatment of uterine fibroids: searching for effective drug therapies","volume":"9","author":"Taylor","year":"2012","journal-title":"Drug Discov Today Ther Strateg"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215018920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215018920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:17:04Z","timestamp":1758010624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028215018920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0015028215018920"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.09.006","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}